1. Home
  2. FPH vs TBPH Comparison

FPH vs TBPH Comparison

Compare FPH & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FPH
  • TBPH
  • Stock Information
  • Founded
  • FPH 2009
  • TBPH 2013
  • Country
  • FPH United States
  • TBPH United States
  • Employees
  • FPH N/A
  • TBPH N/A
  • Industry
  • FPH Real Estate
  • TBPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • FPH Finance
  • TBPH Health Care
  • Exchange
  • FPH Nasdaq
  • TBPH Nasdaq
  • Market Cap
  • FPH 398.9M
  • TBPH 464.5M
  • IPO Year
  • FPH 2017
  • TBPH N/A
  • Fundamental
  • Price
  • FPH $5.34
  • TBPH $9.00
  • Analyst Decision
  • FPH
  • TBPH Buy
  • Analyst Count
  • FPH 0
  • TBPH 4
  • Target Price
  • FPH N/A
  • TBPH $13.75
  • AVG Volume (30 Days)
  • FPH 174.4K
  • TBPH 190.1K
  • Earning Date
  • FPH 04-17-2025
  • TBPH 05-12-2025
  • Dividend Yield
  • FPH N/A
  • TBPH N/A
  • EPS Growth
  • FPH 25.45
  • TBPH N/A
  • EPS
  • FPH 0.96
  • TBPH N/A
  • Revenue
  • FPH $237,926,000.00
  • TBPH $64,381,000.00
  • Revenue This Year
  • FPH N/A
  • TBPH $39.34
  • Revenue Next Year
  • FPH N/A
  • TBPH $3.63
  • P/E Ratio
  • FPH $5.52
  • TBPH N/A
  • Revenue Growth
  • FPH 12.37
  • TBPH 12.12
  • 52 Week Low
  • FPH $2.83
  • TBPH $7.44
  • 52 Week High
  • FPH $6.71
  • TBPH $10.90
  • Technical
  • Relative Strength Index (RSI)
  • FPH 46.37
  • TBPH 41.51
  • Support Level
  • FPH $5.17
  • TBPH $9.05
  • Resistance Level
  • FPH $5.60
  • TBPH $9.55
  • Average True Range (ATR)
  • FPH 0.20
  • TBPH 0.24
  • MACD
  • FPH -0.03
  • TBPH -0.03
  • Stochastic Oscillator
  • FPH 32.30
  • TBPH 12.82

About FPH Five Point Holdings LLC

Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational and recreational elements, as well as civic areas, parks, and open spaces. Its four reportable segments are Valencia, San Francisco, Great Park, and Commercial. It derives the majority of revenue from the Great Park segment which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: